logo-loader

GlobeX Data named among 50 Best Companies to watch in 2020 by The Silicon Review

Last updated: 15:00 04 Aug 2020 EDT, First published: 09:00 04 Aug 2020 EDT

GlobeX Data -
The tech group's solutions are all hosted in Switzerland, which protects users' data from any outside intrusion requests

GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS), the cybersecurity and privacy solutions provider, said it is honoured to have been named as one of the '50 Best Companies To Watch' in 2020 by The Silicon Review.

Silicon Review, according to its website, is the world's most trusted online and print community for business and tech professionals and encompasses nine technology and vertical communities: Software, IT Services, Cloud, Mobile, Big Data, Security, Telecommunications, Hot Start-ups and The Best Companies to work for.

READ: GlobeX Data embraces Goldman Sachs report recommending US tech stocks with foreign exposure

In a statement, Alain Ghiai, CEO and founder of GlobeX, said the accolade was a "testament" to the group's efforts and its dedication to provide the best solutions for security and privacy of data and communications, both for consumers and enterprises worldwide.

"We are excited to have been given this distinction right before our major launch of Sekur later this month https://sekur.com, our encrypted communications solution covering secure email, secure messaging and secure file share," he said.

Ghiai also noted that cybersecurity was a global phenomenon and the firm plans to be present globally in order to help consumers and businesses worldwide.

The tech group's solutions are all hosted in Switzerland, which protects users' data from any outside intrusion requests. The right to privacy is guaranteed in article 13 of the Swiss Federal Constitution.

The article in The Silicon Review can be read by clicking HERE

Shares in Toronto advanced over 14% to C$0.16 each.

---Updates for share price---

Contact the author at giles@proactiveinvestors.com

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

8 hours, 56 minutes ago